Literature DB >> 8465393

Seroepidemiology and serodiagnosis of schistosomiasis in Kenya using crude and purified egg antigens of Schistosoma mansoni in ELISA.

M J Doenhoff1, A E Butterworth, R J Hayes, R F Sturrock, J H Ouma, D Koech, M Prentice, J Bain.   

Abstract

The performance of antibody detection for the diagnosis of schistosomiasis has been evaluated in Kenya. Approximately 1500 blood samples from 3 areas with endemic schistosomiasis (Schistosoma mansoni only, S. haematobium only, and a mixed infection area), and from a non-endemic control area, were tested for their antibody reactivity in an enzyme-linked immunosorbent assay (ELISA). The results were compared with infection status determined by parasitological examination. Two test antigens were used: unfractionated S. mansoni egg homogenate (SEA), and CEF6, a previously described, partially purified fraction of SEA containing 2 cationic antigens. The antigens prepared from eggs of Kenya and Puerto Rico S. mansoni isolates gave very similar results. Bloods from patients with S. haematobium infection cross-reacted significantly with the two S. mansoni antigen preparations, but reactivity against CEF6 appeared more specifically indicative of S. mansoni infection. Of 254 blood samples from schoolchildren in the non-endemic area, 100% gave ELISA optical density readings at 492 nm (OD492) < 0.20 against SEA, and 98% were < 0.20 against CEF6. With 887 blood samples from subjects of all ages in the area endemic for S. mansoni alone, using an ELISA OD492 cut-off point of 0.20, SEA and CEF6 had sensitivities of 94% and 97% respectively, and specificities of 64% and 59% respectively. Increasing the OD492 cut-off value reduced the sensitivity and increased the specificity of both test antigens. Specificity of both antigens was poor with samples from 234 children in an area endemic for both S. mansoni and S. haematobium (< 20% for both antigens at an OD492 cut-off value of 0.20).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8465393     DOI: 10.1016/0035-9203(93)90415-m

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  13 in total

1.  Do intestinal parasites interfere with the seroepidemiologic surveillance of Schistosoma mansoni infection?

Authors:  B Alarcón de Noya; C Colmenares; S Losada; Z Fermin; G Masroua; L Ruiz; L Soto; O Noya
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

2.  Serological speciation of human schistosome infections by ELISA with a panel of three antigens.

Authors:  P Turner; K Lalloo; J Bligh; M Armstrong; C J M Whitty; M J Doenhoff; P L Chiodini
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

3.  Comparison of Recombinant Proteins from Schistosoma japonicum for Schistosomiasis Diagnosis.

Authors:  Ya-mei Jin; Ke Lu; Wei-Fang Zhou; Zhi-Qiang Fu; Jin-Ming Liu; Yao-Jun Shi; Hao Li; Jiao-Jiao Lin
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

4.  Serodiagnosis of imported schistosomiasis by a combination of a commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S. mansoni egg antigens.

Authors:  Tom Van Gool; Hans Vetter; Tony Vervoort; Michael J Doenhoff; Jose Wetsteyn; David Overbosch
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana.

Authors:  Artemis Koukounari; Joanne P Webster; Christl A Donnelly; Bethany C Bray; Jean Naples; Kwabena Bosompem; Clive Shiff
Journal:  Am J Trop Med Hyg       Date:  2009-03       Impact factor: 2.345

Review 6.  Advances in the Diagnosis of Human Schistosomiasis.

Authors:  Kosala G A D Weerakoon; Geoffrey N Gobert; Pengfei Cai; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

7.  Evaluation of the sensitivity of IgG and IgM ELISA in detecting Schistosoma mansoni infections in a low endemicity setting.

Authors:  M C C Espirito-Santo; M C A Sanchez; A R Sanchez; M V Alvarado-Mora; V L P Castilho; E M N Gonçalves; E J A Luna; R C B Gryschek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-17       Impact factor: 3.267

8.  Evaluation of three extraction methods for molecular detection of Schistosoma mansoni infection in human urine and serum samples.

Authors:  Rania M Sarhan; Hanan H Kamel; Ghada A Saad; Ossama A Ahmed
Journal:  J Parasit Dis       Date:  2013-11-20

9.  Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections.

Authors:  Huw Smith; Mike Doenhoff; Cara Aitken; Wendi Bailey; Minjun Ji; Emily Dawson; Henk Gilis; Grant Spence; Claire Alexander; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

10.  Application of DNA-based diagnostics in detection of schistosomal DNA in early infection and after drug treatment.

Authors:  Cen Wang; Lin Chen; Xuren Yin; Wanquan Hua; Min Hou; Minjun Ji; Chuanxin Yu; Guanling Wu
Journal:  Parasit Vectors       Date:  2011-08-24       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.